The difference in the levels of IL-17, IL-6, IL-1β and TNF-α (A) between SLE patients with anti-B19-VP1u IgG [VP1u (+)] and without anti-B19-VP1u IgG [VP1u (−)], and (B) between SLE patients with anti-B19-NS1 IgG [NS1 (+)] and without anti-B19-NS1 IgG [NS1(−)].

Abstract

<p>Data are presented as mean ± SEM. *<i>p</i><0.05, **<i>p</i><0.01, ***<i>p</i><0.005, versus SLE patients without anti-B19-VP1u IgG or anti-B19-NS1 IgG.</p